Research Strategy Board

Our Research Strategy Board (RSB) advises our Board of Trustees on all things relating to research best practice. This includes policies and practices relating to our Research Strategy and activities, plus those which concern reviewing and awarding research grants. 

Members of the RSB advise the charity on matters regarding intellectual property rights, data sharing, ethics, patient and public involvement and engagement (PPIE) in research.  

The RSB typically meets twice a year, with engagement between meetings as and when necessary.  

Find out more about becoming a member of our Research Strategy Board here.

Our Chair

Professor Alan Perkins

Alan PerkinsAlan is a Professor of Medical Physics at the University of Nottingham and Honorary Consultant Clinical Scientist, Nottingham University Hospitals NHS Trust. Professor Perkins is also a member of Coeliac UK having been diagnosed with coeliac disease in 2010 after a brief period of acute anaemia. This was the first time in his life he had been a patient in the hospital he had worked in for 30 years. He brings not only a personal insight into the condition but vast expertise in research, and along with the Board, will help us to work towards a step change in research into coeliac disease.

 

Other members of the Research Strategy Board

Professor Julia Gog OBE

Professor Julia Gog OBE

Professor of Mathematical Biology, University of Cambridge, and Fellow of Queens’ College, Cambridge. Diagnosed with coeliac disease in 2017.

Louise Hawkes

Louise Hawkes

Louise works as a project manager in clinical development of new medicines. She has a BSc in Biology & Statistics, a PGDip in Clinical Sciences, and has worked in the pharmaceutical sector for 30 years. Her 16 year old son was diagnosed with coeliac disease during the COVID lockdown and her involvement with the Research Strategy Board is prompted by both scientific and personal experience. Helping a teenager to adjust to a new lifestyle, and educating those around us and further afield is proving challenging and she would like to support the critical work that Coeliac UK do, providing education and information, supporting essential research and also advocating for new treatments and care for coeliac patients.

Professor Paul Klenerman

Professor Paul Klenerman

Immunologist, University of Oxford and John Radcliffe Hospital.

MM1

Dr Michael Murray

Works with the development and commercialisation of intellectual assets. He has previously been involved with the development of a new therapy for coeliac disease. He has a PhD in molecular genetics and a first degree in microbiology.

Dr Katharine Reeves

Dr Katharine Reeves

After completing her PhD in Economics, Katharine joined the Health Informatics Research Team at University Hospitals Birmingham as a Statistician. She works with both academics and clinicians to answer specific research questions using routinely collected hospital data. Katharine is a member of Coeliac UK having been diagnosed with coeliac disease in 2019.

Prof Jeremy Woodward

Dr Jeremy Woodward

Completed a PhD in immunology prior to his appointment as a consultant gastroenterologist at Addenbrooke’s Hospital, Cambridge. He is the lead clinician for nutrition and chairs the Trust nutrition steering group. He provides specialist clinics in coeliac disease.

The RSB will advise our Board of Governors on the best practice for reviewing and awarding research grants and any necessary policies relating to our Research Strategy, including intellectual property rights, data sharing and ethics.